Pacific Biometrics Schedules Third Quarter Conference Call for Monday, May 18, 2009

SEATTLE, WA, May 11 (MARKET WIRE) --
Pacific Biometrics, Inc. (OTCBB: PBME), which provides specialty
reference laboratory services to support pharmaceutical and laboratory
diagnostic manufacturers in the conduct of human clinical research, today
announced that it has scheduled an investor conference call for 11:00
a.m. EDT on Monday, May 18, 2009 to review the Company's operating
results for the third quarter and first nine months of FY2009. The
Company will report its operating results for the quarter and nine months
ended March 31, 2009 before the market opens on May 18, 2009.

Shareholders and other interested parties may participate in the
conference call by dialing 800-860-2442 (international/local participants
dial 412-858-4600) and requesting participation in the "Pacific
Biometrics, Inc. Conference Call" a few minutes before 11:00 a.m. EDT on
May 18, 2009. A replay of the conference call will be available one hour
after the call through May 27, 2009 at 9:00 a.m. EDT by dialing
877-344-7529 (international/local participants dial 412-317-0088) and
entering the Conference ID 430456.

About Pacific Biometrics, Inc. (PBI)

Established in 1989, PBI provides specialized central laboratory and
contract research services to support pharmaceutical and diagnostic
manufacturers conducting human clinical trial research, including expert
services in the areas of cardiovascular disease, diabetes, osteoporosis,
arthritis, and nutrition. The PBI laboratory is accredited by the College
of American Pathologists, New York State, and the Lipid Standardization
Program. PBI's clients include many of the world's largest pharmaceutical,
biotech, and diagnostic companies.

Pacific Biomarkers, a wholly owned subsidiary of PBI, focuses specifically
on the emerging field of biomarker assay development and testing. Services
include validating and performing ligand-binding assays for novel clinical
biomarkers, immunogenicity testing, and multiplex testing.

PBI is headquartered in Seattle, Washington, and its common stock trades
on the OTC Bulletin Board under the symbol "PBME." For more information
about PBI, visit the company's web site at www.pacbio.com.

For further information, please contact:

Ronald R. Helm
Chairman & CEO
(206) 298-0068

or

RJ Falkner & Company, Inc.
Investor Relations Counsel
(830) 693-4400
or via e-mail at Email Contact

Copyright 2009, Market Wire, All rights reserved.

-0-